Daré Bioscience, Inc. (DARE) Social Stream



Daré Bioscience, Inc. (DARE): $1.10

0.02 (+1.39%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add DARE to Watchlist
Sign Up

Industry: Biotech


Ranked

of 392

in industry

Dare Bioscience Inc (DARE) Price Targets From Analysts

Use the tables below to see what analysts covering Dare Bioscience Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-08 5 $11 $3 $5.4 $1.54 250.65%
2022-01-19 5 $11 $3 $5.6 $1.54 263.64%

The Trend in the Analyst Price Target


DARE's average price target has moved up $0.1 over the prior 144 days.

DARE reports an average of 238.22% for its upside potential over the past 41 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-22 0 9 3 5.0 1.44 247.22%
2021-06-05 0 9 3 5.0 1.27 293.7%
2021-08-13 5 11 3 5.4 1.60 237.5%
2021-08-28 5 11 3 5.4 1.74 210.34%
2022-01-19 6 11 3 5.6 1.61 247.83%

DARE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 5 0 0 0 0 5

The Trend in the Broker Recommendations


DARE's average broker recommendation rating improved by 0 over the prior 31 days.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how Dare Bioscience Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -290.22% of that group.
  • In terms of how Dare Bioscience Inc fares relative to all US stocks, note that its average analyst price target is greater than 13.35% of that group.
  • In terms of how Dare Bioscience Inc fares relative to stocks in the micro market cap category, note that its number of analysts covering the stock is greater than 364% of that group.
  • To contextualize these metrics, consider that out of Healthcare stocks, Dare Bioscience Inc's upside potential (average analyst target price relative to current price) is higher than 273.64% of them.

Stocks similar to Dare Bioscience Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CYCC, CWBR, and CPHI.

Is DARE a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6409 seconds.